SAKAR2025-10-012025-12-31SAKAR2025-04-012025-12-31SAKAR2025-10-012025-12-31in-capmkt:OtherExpenses1MemberSAKAR2025-04-012025-12-31in-capmkt:OtherExpenses1MemberSAKAR2025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1SAKAR2025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares000000SAKARNOTLISTEDINE732S01012Sakar Healthcare LimitedMain BoardEquity2025-04-012026-03-312026-02-052026-01-30INRLakhsQuarterlyThird quarterSingle segmentPharmaceuticals2026-02-0510:00:002026-02-0510:20:00Not applicable2025-10-012025-12-31UnauditedConsolidated70342400050770007085010003854240000-3005300098874000177540006372700063251000598977000109524000010952400007034000703400001024900000000102490000-267000102223000222499000104.594.59004.594.591. The Company is operating only in one segment. Hence segment reporting is not given. <BR> <BR> 2. The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder. <BR> <BR> 3. The Company has a wholly owned subsidiary vis. M/s. Sakar Oncology Private Limited. Other than this, the Company does not have any subsidiary/ associate. <BR> <BR> 4. Provision for taxation/deferred taxation, if any, will be made at the year end. <BR> <BR> 5. Figures, wherever required, are regrouped / rearranged. <BR> <BR> 6. The above results have been reviewed by audit committee and approved by Board of Directors of Company at its meeting held on 5th February, 2026 <BR> <BR> Please note that for Quarter ended 31-12-2025, the Current tax is Rs. 183.05 lacs and MAT Credit Entitlement is Rs. (183.05 lacs) hence the net effect is NIL. And for nine months ended 31-12-2025, the Current tax is Rs. 374.24 lacs and MAT Credit Entitlement is Rs. (374.24 lacs) hence the net effect is NIL <BR> <BR> <BR> <BR> <BR> <BR> 2025-04-012025-12-31UnauditedConsolidated18063900002116200018275520009690980000-2013900025778900054448000176288000173117000161060100021695100002169510000223500002235000001946010000000194601000-801000193800000222499000108.718.71008.718.71Other expenses63251000Other expenses173117000Re-measurement gains/(losses) on defined benefit plans-370000-370000Re-measurement gains/(losses) on defined benefit plans-1110000-1110000-103000-30900000-267000-801000